LNSR logo

LENSAR Inc. (LNSR)

$4.91

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on LNSR

Market cap

$60364723

EPS

-0.37

P/E ratio

--

Price to sales

1.3

Dividend yield

--

Beta

1.033821

Price on LNSR

Previous close

$5.29

Today's open

$5.27

Day's range

$4.89 - $5.40

52 week range

$4.30 - $12.94

Profile about LNSR

CEO

Nicholas T. Curtis

Employees

150

Headquarters

Orlando, FL

Exchange

NASDAQ Capital Market

Shares outstanding

12294241

Issue type

Common Stock

LNSR industries and sectors

Healthcare

Medical Equipment & Supplies

News on LNSR

LENSAR Q3 Earnings Call Highlights

LENSAR NASDAQ: LNSR reported a slight decline in third-quarter revenue as lower sales of its cataract surgery systems offset growth in procedure and other recurring revenue. The company said its installed base and procedure volume continued to expand, while its operating loss narrowed from a year earlier.

news source

MarketBeat • Nov 10, 2026

news preview

LENSAR, Inc. (LNSR) Q3 2026 Earnings Call Transcript

LENSAR, Inc. (LNSR) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 10, 2026

news preview

LENSAR® Reports Third Quarter 2026 Financial Results and Provides Business Update

10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Third Quarter 2026; Backlog of 12 ALLY Systems as of September 30, 2026 Third Quarter Recurring Revenue Grew 17% Year Over Year to $12.6 Million Total Laser Installed Base Reaches 450 Systems; ALLY System Installed Base Expands 22% Year Over Year ORLANDO, Fla., Nov. 10, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2026 and provided an update on key operational initiatives.

news source

GlobeNewsWire • Nov 10, 2026

news preview

LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026

ORLANDO, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company's third quarter 2026 financial results will be released before market open on Tuesday, November 10, 2026.

news source

GlobeNewsWire • Nov 3, 2026

news preview

Cedar Grove Capital Q3 2026 Portfolio Update

During the quarter, we closed our long positions in MTY Food Group, uniQure, ClearPoint Neuro, and Suja Life Inc. During the quarter, we closed short positions in Bending Spoons SpA, Chipotle Mexican Grill, The Ensign Group, Gemini Space Station, Jersey Mike's Subs, Moderna, Reformation, Once Upon a Farm, and X-Energy Inc. We initiated a small tracking position in Zedcor Inc. while continuing our due diligence.

news source

Seeking Alpha • Oct 7, 2026

news preview

LENSAR Q2 Earnings Call Highlights

LENSAR NASDAQ: LNSR reported second-quarter 2026 revenue growth of 18% as the company continued to rebuild commercial momentum following the termination of its proposed merger with Alcon near the end of the first quarter.

news source

MarketBeat • Aug 13, 2026

news preview

LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript

LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Aug 13, 2026

news preview

LENSAR® Reports Second Quarter 2026 Results and Provides Business Update

10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026 Second Quarter Recurring Revenue was $13.7 million Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on key operational initiatives.

news source

GlobeNewsWire • Aug 13, 2026

news preview

LENSAR Q1 Earnings Call Highlights

LENSAR NASDAQ: LNSR executives told investors on Thursday that the company is moving past a “transaction-related holding pattern” after the termination of its planned merger, and is now refocusing on rebuilding commercial momentum around its ALLY femtosecond laser cataract platform. Management said first-quarter results reflected that period of uncertainty, but highlighted continued growth in recurring revenue and rising procedure volumes.

news source

MarketBeat • May 8, 2026

news preview

LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript

LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript

news source

Seeking Alpha • May 8, 2026

news preview

¹ Disclosures

Get started with M1

Invest in LENSAR Inc.

Open an M1 investment account to buy and sell LENSAR Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in LNSR on M1